Philips and Reinier de Graaf Hospital Expand Existing Strategic Partnership

PhilipsRoyal Philips N.V. (NYSE: PHG, AEX: PHIA) and the 622-bed Reinier de Graaf hospital (Delft, the Netherlands) have announced the signing of an additional 15-year partnership agreement. The agreement, which will give the entire hospital long-term continuous access to Philips' advanced diagnostic and interventional ultrasound technologies, represents a significant extension of an existing multi-year partnership entered into in September 2014. Being the most extensive and holistic agreement for ultrasound ever signed by Philips in the Netherlands, this new agreement emphasizes Philips' global technology leadership in medical ultrasound as well as its role as an accountable business partner.

The new agreement applies to all of the hospital's departments and sites, including a new principal site that will open in August of this year. This latest generation of ultrasound systems being supplied as part of the agreement will offer simplified workflows and a powerful combination of speed and image clarity. The systems will be used, among other applications, for abdominal examinations and for examinations during pregnancy, but will also play an important role in the treatment of rheumatism and the image-guided treatment of patients with cardiovascular disease, performed using the latest live 3D imaging technologies.

This next step in the collaboration between Reinier de Graaf hospital and Philips marks a substantial expansion of the existing partnership between Philips and Reinier de Graaf. The existing partnership already gives the hospital fast and continuous access to the latest diagnostic and interventional imaging systems and clinical informatics solutions as well as innovative planning and consultancy services to help improve the quality and efficiency of healthcare provision. With current and future health care developments in mind, flexibility is one of the core elements of this partnership, enabling the optimal level of patient care and operational efficiency.

Working with a single family of ultrasound systems, all with similar interfaces and usability, hospital personnel will soon be able to work with ultrasound more easily and more efficiently. Ultrasound systems will be easily interchangeable between healthcare professionals and departments - for example, when additional capacity or functionality is needed. Training hospital personnel will also be more efficient.

"Reinier de Graaf carefully considered which ultrasound systems will be required after the move to our new hospital site," said Jaap van den Heuvel, CEO Reinier de Graaf hospital. "We firmly believe that we now have a balanced package that will enable every department to offer the required ultrasound diagnostics. Thanks to this partnership collaboration with Philips, we will now be able to tailor our equipment in a flexible way to suit future developments."

"Philips is changing from a supplier of medical technology to a service provider that supports hospitals across the healthcare continuum, both in terms of the quality of healthcare and in terms of performance and efficiency," said Henk Valk, General Manager of Philips Healthcare Benelux. "We are finding that hospitals are increasingly opting for this strategic partnership model. The new agreement with the Reinier de Graaf hospital shows how, through partnerships like these and the experiences and the relationship of trust that arise from them, we are able to explore additional areas where we can deliver added value for one another."

The new ultrasound systems will be operational with effect from May of this year. Philips is a global leader in medical ultrasound. Thanks to its cost-effectiveness and flexibility, ultrasound is one of the fastest-growing imaging modalities in the market. With its technology leadership, Philips has been able to build a broad and complete portfolio of ultrasound solutions for both diagnostics and interventional therapy.

Related news articles:

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people's lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2014 sales of EUR 21.4 billion and employs approximately 108,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare.

Most Popular Now

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Routine AI Assistance may Lead to Loss o…

The introduction of artificial intelligence (AI) to assist colonoscopies is linked to a reduction in the ability of endoscopists (health professionals who perform colonoscopies) to detect precancerous growths (adenomas) in...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...